Le Dexone Générique est utilisé pour traiter certaines conditions associées à une diminution du fonctionnement des glandes adrénales. Il est également utilisé pour traiter l'inflammation grave due à certaines conditions, incluant l'asthme sévère, les allergies sévères, l'arthrite rhumatoïde, les colites ulcératives, certains troubles du sang, le lupus, la sclérose en plaques, et certaines conditions des yeux et de la peau.
Celtic Pharma Announces Successful Completion of Phase I/II study of Xerecept ... - MarketWatch (press release)
Celtic Pharma Announces Successful Completion of Phase I/II study of Xerecept .
Celgene announces three phase III Revlimid trials in newly diagnosed MM patients - pharmabiz.com
Celgene announces three phase III Revlimid trials in newly diagnosed MM patientspharmabiz.
Suspected illegal supply of Western medicine by Chinese medicine practitioner - 7thSpace Interactive (press release)
Suspected illegal supply of Western medicine by Chinese medicine practitioner7thSpace Interactive (press release)'The Government Laboratory's analysis results today detected the presence of dexamethasone and ketoconazole in a sample of the yellowish cream provided by the complainant, both of which could attain therapeutic levels if used in accordance with the .
The Oncology Report Short List of Lymphoma and Multiple Myeloma Trials - The Oncology Report
The Oncology Report Short List of Lymphoma and Multiple Myeloma TrialsThe Oncology Report• Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs.
Chemo combination promising for multiple myeloma - Medical Xpress
Chemo combination promising for multiple myelomaMedical XpressFor patients with relapsed or refractory multiple myeloma, combination treatment with elotuzumab, lenalidomide, and low-dose dexamethasone is generally well tolerated, with encouraging response rates, according to a study published online April 30 in .